Vimarsana
Biggest News Aggregation in the World

Antonio Payano News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Antonio Payano. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Antonio Payano Today - Breaking & Trending Today

Bayer Digital Health UKI introduces new technology to help type 2 diabetes patients manage kidney health - Vimarsana News

Bayer Digital Health UKI introduces new technology to help type 2 diabetes patients manage kidney health

Bayer Digital Healthcare UKI has today announced the launch of its first digital patient support package, My Kidney Assistant, designed to provide type 2 diabetes (T2D) patients with the information and resources to help monitor and improve their kidney health.

10 Charged in $20 Million Scheme to Sell Black-Market H.I.V. Drugs - Vimarsana News

10 Charged in $20 Million Scheme to Sell Black-Market H.I.V. Drugs

Federal prosecutors said the defendants encouraged low-income patients to sell their medication to them and then resold the drugs and used the money to buy luxury goods.

Life sciences leaders unite to condemn radical plans to rewrite medicines scheme - Vimarsana News

Life sciences leaders unite to condemn radical plans to rewrite medicines scheme

Life sciences leaders unite to condemn radical plans to rewrite medicines scheme

UK medicines revenue clawback rockets to 26.5% putting Life Sciences Vision at risk, says ABPI - Vimarsana News

UK medicines revenue clawback rockets to 26.5% putting Life Sciences Vision at risk, says ABPI

UK medicines revenue clawback rockets to 26.5% putting Life Sciences Vision at risk, says ABPINext year manufacturers of branded medicines will be required to return almost £3.3bn in sales revenue to the government (26.5% of sales), up from around £0.6bn in 2021 and £1.8bn in 2022 [1].Company react...

NHS England to fast-track prostate drug which can prolong survival by years - Vimarsana News

NHS England to fast-track prostate drug which can prolong survival by years

It will be the first health service in Europe to offer it after a post-Brexit partnership between UK, US and Australian medicines regulators